Heterocyclic compounds and their uses

Details for Australian Patent Application No. 2010265932 (hide)

Owner Amgen Inc.

Inventors Cushing, Timothy D.; Dransfield, Paul John; Gonzalez Lopez De Turiso, Felix; Johnson, Michael G.; Kohn, Todd J.; Pattaropong, Vatee; Simard, Jillian L.

Agent Shelston IP

Pub. Number AU-A-2010265932

PCT Pub. Number WO2010/151791

Priority 61/220,259 25.06.09 US

Filing date 25 June 2010

Wipo publication date 29 December 2010

International Classifications

C07D 215/44 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/151791 Priority application(s): WO2010/151791

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010265933-Readily isolated bispecific antibodies with native immunoglobulin format

2010265912-Azeotropic and azeotrope-like compositions of Z1,1,1,4,4,4-hexafluoro-2-butene, trans1,2-dichloroethylene, and a third component